SCHEMBL5482709

SCHEMBL5482709

CS(=O)(=O)Nc1ccc(Oc2ccc3c(c2)S(O)(O)NCN3CCF)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.41
GRIA2 P42262 8/20 0.40
PGR P06401 1/20 0.40
MMP2 P08253 2/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP14 P50281 1/20 0.37
MMP1 P03956 1/20 0.37
GRIN1 Q05586 2/20 0.35
GRIN2B Q13224 2/20 0.35
SLC6A4 P31645 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
MMP13 P45452 1/20 0.34
CHEK2 O96017 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5484644 0.92 GRIA2 (0.40) GRIA2PGRGRIN1GRIN2BSLC6A4
SCHEMBL5482710 0.89 GRIA2 (0.54) LTA4HGRIA2PGRMMP2MMP3
SCHEMBL5479955 0.87 GRIA2 (0.39) GRIA2SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL5482327 0.82 GRIA2 (0.39) GRIA2
SCHEMBL5484649 0.81 GRIA2 (0.51) GRIA2PGR
SCHEMBL5621041 0.80 GRIA2 (0.40) GRIA2PGRGRIN1GRIN2BLMNA
SCHEMBL2178746 0.80 GRIA2 (0.58) LTA4HGRIA2PGRMMP2MMP3
SCHEMBL5479901 0.77 GRIA2 (0.39) GRIA2SLC6A4SLC6A2SLC6A3LMNA
SCHEMBL5479485 0.72 GRIA2 (0.38) GRIA2LMNA
SCHEMBL5475951 0.71 GRIA2 (0.68) GRIA2MMP2MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655030-B1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB (FR) 2007-12-19 EP disclosed
US-20070270415-A1 Benzothiadiazine compounds LESLABORATOIRES SERVIER (FR) 2007-11-22 US disclosed
US-7268130-B2 Benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-09-11 US disclosed
EP-1655030-A1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same Les Laboratoires Servier (FR) 2006-05-10 EP disclosed
US-20060094712-A1 New benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270415-A1 Benzothiadiazine compounds SLC1A1, SLC1A2, SULT2A1 LTA4H 2272/4885GRIA2 47/4885PGR 2853/4885
US-20060094712-A1 New benzothiadiazine compounds SLC1A1, SLC1A2, GABRA5 LTA4H 1985/4885GRIA2 36/4885PGR 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.